| Followers | 9 |
| Posts | 3229 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Saturday, April 04, 2026 7:44:16 AM
First of all, it was NOT 900 million extra shares to print and sell. She was already way over the 1.7 billion authorized before the increase.
As of the last SEC filing and with the current outstanding shares, there are about 2.2 Billion shares outstanding fully diluted. (There were about 620+ Million "potentially dilutive securities" as per the last 10K filing)
So with 2.6 Billion now authorized, she only has about 400 Million left to dump on people.
BP is never gonna buy 1 single share of that, not at $10, not at $0.10 cents and not even at 1 penny! There will never be a short squeeze either.
I don't know where you get your ideas and information from, but I suggest you change the source and speak to a financial professional. You are misleading others as well as deluding yourself.
Just my opinions, GL to all.
As of the last SEC filing and with the current outstanding shares, there are about 2.2 Billion shares outstanding fully diluted. (There were about 620+ Million "potentially dilutive securities" as per the last 10K filing)
So with 2.6 Billion now authorized, she only has about 400 Million left to dump on people.
BP is never gonna buy 1 single share of that, not at $10, not at $0.10 cents and not even at 1 penny! There will never be a short squeeze either.
I don't know where you get your ideas and information from, but I suggest you change the source and speak to a financial professional. You are misleading others as well as deluding yourself.
Just my opinions, GL to all.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
